Lhasa Limited

📣 The deadline for the 2024 Richard Williams Award is fast approaching, closing on the 7th of November. https://buff.ly/3zEpEW2 Read our latest #blog post, featuring an interview with the 2023 Richard Williams Award winner, Raj Gandhi, PhD from AstraZeneca. We discussed his award-winning work, career journey, and more! Read the article: https://buff.ly/3UubjCB

Last week, BITEK Chems attended the 134th General Meeting & Exhibition of the Korean Chemical Society (KCS). We were thrilled to see so many attendees visit our booth and connect with the BITEK team💡 #ChemicalSafety

Join our webinar in #Spanish, discussing API safety through effective impurity and degradant management under ICH M7! 💊 📅 28 November 🕙 10:00 - 12:00 COT / 12:00 - 14:00 ART / 16:00 - 18:00 CEST 🗣️ Spanish 🔗 https://buff.ly/3Umwgzn Lucía Toscano Bayona, Application Scientist at Lhasa Limited ➡ Lucia will showcase how Zeneth predicts degradation pathways and aids in identifying potential impurities, streamlining #API risk assessment and degradation product characterisation. Dr Maria Celeste del Fueyo, PhD, Application Scientist at Lhasa Limited ➡ Celeste will highlight how Derek Nexus (expert knowledge-based) and Sarah Nexus (statistical-based) provide robust (Q)SAR assessments, predicting mutagenic and carcinogenic potential for comprehensive ICH M7 risk evaluation. Dr Mariana Mendez, Manager of Bioanalytical Development and Genotoxic Impurities at Baliarda S.A. ➡ Mariana will share insights into how Baliarda conduct #ICHM7 risk assessment through a real-world case study on an API. Register now: https://buff.ly/3Umwgzn #Webinar #Pharmaceutical

We are delighted to be taking part in an online seminar and panel discussion with Thermo Fisher Scientific! Join this panel of experts as they examine the challenge of NDSRI analysis including matrix effects, and the risk of false positive results arising during sample preparation. 💻 29th October, 12pm (EDT) / 4pm (GMT) Join our Senior Global Alliances Manager Grace Kocks, as the panel present and discuss: 🔹 Nitrites in excipients 🔹 Nitrite and NDSRI analysis methods and challenges 🔹 NDSRI risk assessment 🔹 The industry accessible NDSRI database hosted by Lhasa Limited Sign up to the webinar here: https://buff.ly/3YicE0H

We're excited to participate in the American College of Toxicology (ACT) 2024 annual convention in Austin, Texas next month! Our Senior Application Scientist, Dr Charlie Modlin, will be leading an industry hosted session discussing: 𝗦𝗲𝘁𝘁𝗶𝗻𝗴 𝗹𝗶𝗺𝗶𝘁𝘀 𝗳𝗼𝗿 𝗻𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲𝘀 𝗮𝗻𝗱 𝗼𝘁𝗵𝗲𝗿 𝗶𝗺𝗽𝘂𝗿𝗶𝘁𝘆 𝗰𝗹𝗮𝘀𝘀𝗲𝘀 𝘂𝘀𝗶𝗻𝗴 𝗶𝗻 𝘀𝗶𝗹𝗶𝗰𝗼 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀, 𝗶𝗻𝗰𝗹𝘂𝗱𝗶𝗻𝗴 𝗿𝗲𝗮𝗱-𝗮𝗰𝗿𝗼𝘀𝘀 On Tuesday 19th November from 12:00 – 12:55, learn how the Lhasa carcinogenic potency categorisation approach (CPCA) tool can enhance your impurity assessment, and how to determine compound-relevant limits for these impurity types using an in silico read-across workflow. We will also be exhibiting at the meeting in Booth 313 – so if you're attending, we can’t wait to see you there! Find out more: https://buff.ly/4f8F3Nd

Dive into our latest #blog where we tackle 10 frequently asked questions about Mirabilis. 🔍 Identification and control of impurities in active pharmaceutical ingredients (APIs) and pharmaceutical drug products is critical in drug development. Mirabilis is our innovative solution designed to address this challenge. In this post, we’ll answer ten frequently asked questions! https://buff.ly/485nqMd #InSilico #DrugDevelopment #PMIs #Mutagenic #Impurities #ICHM7

Great to see a full house at our Lhasa symposium in Seoul, South Korea, alongside BITEK CHEMS. 💙

It’s been a pleasure to present on Lhasa Limited’s new #readacross tool Acrostic in the Lhasa Limited/Bitek Chems symposium in Seoul just now - I even took advantage of some of the hills surrounding this bustling city to collect extra supporting evidence for the mountaineering analogy… If you haven’t heard this, you’re missing out, so get in touch via https://lnkd.in/eK9SSmBD to find out more about Acrostic and how we can support your #chemicalsafety decisions, for #nitrosamines and beyond!

What a day, what a team! 😍 Last week our Lhasa Limited IT team came together for an incredible team building day that was both fun and productive. We started with a unique 'washing instructions' activity, which gave us the opportunity to understand how our colleagues prefer to work, their expectations, get to know each other better and build empathy and respect for our differences. Following that, we had a productive IT360 brainstorming session where we identified gaps and opportunities based on our core pillars: IT as one team, user experience, security by design, member confidence, resilience, and robustness. To wrap up the day, we enjoyed a fun and highly competitive pub quiz, which brought out the best in everyone and strengthened our team spirit. Feeling grateful for such a dedicated and collaborative team. 🚀 And of course, we couldn't end the day without our traditional photo in front of the blue door. 📸 #informationtechnology #collaboration #teambuilding #diversity

We are delighted to be taking part in an online seminar and panel discussion with Thermo Fisher Scientific! Join this panel of experts as they examine the challenge of NDSRI analysis including matrix effects, and the risk of false positive results arising during sample preparation. 💻 29th October, 12pm (EDT) / 4pm (GMT) Join our Senior Global Alliances Manager Grace Kocks, as the panel present and discuss: 🔹 Nitrites in excipients 🔹 Nitrite and NDSRI analysis methods and challenges 🔹 NDSRI risk assessment 🔹 The industry accessible NDSRI database hosted by Lhasa Limited Sign up to the webinar here: https://buff.ly/3YicE0H